News
-
-
PRESS RELEASE
Logwin reports revenue growth in the first half of 2026
Logwin reports revenue growth in the first half of 2026 amidst a challenging market environment, with revenues increasing to EUR 737.4m. The company's solid financial position and strategic expansion in the U.S. market were highlighted -
-
-
-
PRESS RELEASE
Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz receives regulatory approval for Owozy®, a new semaglutide treatment for type-2 diabetes in Brazil, enhancing patient access and supporting local healthcare systems -
-
-
-